Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Kutok joins Epizyme as CSO; plus ADC Therapeutics, Emulate, E-Scape, MiMedx and RubrYc

March 21, 2020 12:50 AM UTC

Epizyme Inc. (NASDAQ:EPZM) hired Jeffery Kutok as CSO. He was EVP and CSO of Infinity Pharmaceuticals Inc. (NASDAQ:INFI). Kutok joins the epigenetics company in the wake of its first FDA approval, for Tazverik tazemetostat to treat epitheliod sarcoma (see "Epizyme Scores First FDA Approval").

Antibody-drug conjugate company ADC Therapeutics S.A. appointed Ron Squarer as chairman. He succeeds Peter Corr, who will remain on the board. Squarer was CEO of Array BioPharma Inc...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article